<DOC>
	<DOCNO>NCT00002848</DOCNO>
	<brief_summary>RATIONALE : Developing cop strategy may help improve quality life patient prostate cancer . PURPOSE : This randomized clinical trial compare effect group therapy write educational material quality life men stage I stage II prostate cancer .</brief_summary>
	<brief_title>Group Therapy Compared With Educational Materials Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility provide group support , evaluate effect supportive-expressive group therapy vs. write educational material psychological health quality life men stage I/II prostate cancer . OUTLINE : Patients stratify prior hormonal therapy . Patients continue standard oncologic treatment concurrently supportive-expressive group therapy . Supportive-expressive group therapy consist twelve 90-minute weekly meeting 8-12 member 2 cotherapists base follow theme : building bond , express emotion , detoxify dying , take time prioritize set realistic goal , fortify family , deal doctor . Each session commences brief stress reduction exercise end brief cognitive restructuring imagery exercise . The main portion meeting emphasize provide environment patient share concern , feeling , thought openly honestly . The role cotherapist facilitate expression patient ' concern , offer empathy , continue encourage patient express feeling thought . Quality-of-life questionnaire fill 3 6 month every 6 month total 2 year . PROJECTED ACCRUAL : Approximately 480 patient ( include estimate 53 minority patient ) enter multicenter study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven prostate cancer diagnose within 1 year prior entry Clinical stage I/II ( T1bc T2 , N0 Nx , M0 ) disease Pathologic local upstaging ( e.g. , T3 ) allow No Nx disease pathologic partial pathologic ( e.g. , lymph node biopsy dissection ) staging perform No major psychiatric illness require hospitalization medication depression anxiety less 1 year No second malignancy within 10 year except nonmelanomatous skin cancer Clinical followup urologist , medical oncologist , radiation therapist require least semiannually PATIENT CHARACTERISTICS : Age Not specify Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other See Disease Characteristics PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
</DOC>